Acrivon Therapeutics, Inc. Common Stock (ACRV)

$1.45 +3.96%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-13 ESTIMATED
search

Acrivon Therapeutics, Inc. Common Stock (ACRV) has reported earnings 14 times since Mar 28, 2023. The stock moves an average of ±11.61% the day after reporting, closing higher 42.9% of the time. Its largest post-earnings gain was +16.01% (Mar 28, 2024) and its largest decline was -53.29% (Mar 25, 2025). The next earnings report is predicted for 2026-08-13 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

14

Avg Abs. Movement

±11.61%

Positive %

42.9%

Negative %

57.1%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 13, 2026 ☽ POST $1.90 $1.93 $1.91 9,171 +1.05% open_in_new
Mar 19, 2026 ☀ PRE $1.59 $1.73 $1.71 22,270 +4.27% open_in_new
Nov 13, 2025 ☽ POST $2.19 $2.19 $2.07 10,145 +7.97% open_in_new
Aug 13, 2025 ☽ POST $1.30 $1.33 $1.33 3,402 +3.76% open_in_new
May 14, 2025 ☽ POST $1.10 $1.16 $1.14 16,289 -1.32% open_in_new
Mar 25, 2025 ☽ POST $5.47 $5.47 $5.39 6,146 -53.29% open_in_new
Nov 13, 2024 ☀ PRE $8.09 $8.09 $7.99 912 -5.61% open_in_new
Aug 13, 2024 ☀ PRE $7.54 $7.54 $7.24 2,474 -4.92% open_in_new
May 14, 2024 ☀ PRE $8.80 $8.80 $8.35 2,586 -1.01% open_in_new
Mar 28, 2024 ☀ PRE $6.08 $7.26 $7.10 3,652 +16.01% open_in_new
Nov 09, 2023 ☀ PRE $5.18 $5.18 $4.56 321 -20.21% open_in_new
Aug 11, 2023 ☀ PRE $12.59 $12.59 $12.59 824 +6.02% open_in_new
May 09, 2023 ☀ PRE $13.34 $13.34 $12.87 1,019 -36.13% open_in_new
Mar 28, 2023 ☀ PRE $13.85 $13.85 $13.52 1,067 -0.99% open_in_new
event

Earnings Count

14

Total earnings in dataset

trending_up

Avg Abs. Movement

±11.61%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
4 20260526 open_in_new SEC.gov
DEFA14A 20260522 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov
4 20260520 open_in_new SEC.gov

Frequently asked about ACRV earnings

When does Acrivon Therapeutics, Inc. Common Stock report earnings next? expand_more

Acrivon Therapeutics, Inc. Common Stock (ACRV)'s next earnings date is estimated for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ACRV stock move after earnings? expand_more

Over 14 reports, ACRV has moved an average of ±11.61% the session after earnings, closing higher 42.9% of the time.

What was ACRV's biggest post-earnings move? expand_more

ACRV's largest post-earnings gain on record was +16.01% on Mar 28, 2024, and its largest decline was -53.29% on Mar 25, 2025.

Where can I find Acrivon Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Acrivon Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers